Researchers have successfully demonstrated the first preventive treatment against peanut allergy. The drug, which raises the threshold at which allergic people react to peanuts, could reach the market in 2 to 3 years, the scientists say.
In some ways, a peanut allergy is the worst kind, says Hugh A. Sampson of Mount Sinai School of Medicine in New York.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.